HeLa S3 ATG3 KO

By Marvin Skulsuppaisarn
View Published Lab Material

Output Details

Description
HeLa S3 ATG3 KO, CVCL_C7IT Population: African American. Knockout cell: Method=CRISPR/Cas9; HGNC; 20962; ATG3. Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Miscellaneous: Cell line information from personal communication of Skulsuppaisarn M. Derived from sampling site: Uterus; cervix.
Tags
  • Human
Team
Team Hurley
Program
Collaborative Research Network
Theme
PD Functional Genomics

Meet the Authors

  • User avatar fallback logo

    Marvin Skulsuppaisarn

Related Research

Three-step docking by WIPI2, ATG16L1 and ATG3 delivers LC3 to the phagophore

In this manuscript, in a near-complete pathway from initial membrane recruitment to LC3 lipidation reaction, we show how a three-step targeting mechanism of the ATG12-ATG5-ATG16L1 machinery ensures a high level of regulatory control on autophagy.

View Article

L1-silenced iPSC line (HS1_L1HS-CRISPRi_g1)

Human iPSCs were modified with CRISPRi to target LINE-1 retrotransposons, creating stable cell lines with different genetic backgrounds and guide RNAs. These resources are detailed in Adami et al. (DOI: 10.1016/j.xgen.2025.100979).

View Lab Material

L1-silenced iPSC line (HS1_L1HS-CRISPRi_g2 )

Human iPSCs were modified with CRISPRi to target LINE-1 retrotransposons, creating stable cell lines with different genetic backgrounds and guide RNAs. These resources are detailed in Adami et al. (DOI: 10.1016/j.xgen.2025.100979).

View Lab Material
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.